Preferred Label : clinical trials, phase iii as topic;

MeSH definition : Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.;

MeSH synonym : clinical trials, phase 3 as topic;

MeSH hyponym : evaluation studies, FDA phase III as topic; Drug Evaluation, FDA Phase III as Topic; Drug Evaluation, FDA Phase 3 as Topic; Evaluation Studies, FDA Phase 3 as Topic;

MeSH annotation : for general design, methodology, economics, etc. of phase III clinical trials; a different heading CLINICAL TRIAL, PHASE III is used for reports of a specific phase III clinical trial;

Details


Main resources

You can consult :

Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.

http://medecine-pharmacie.univ-rouen.fr/jsp/saisie/liste_fichiergw.jsp?OBJET=DOCUMENT&CODE=1183043894203&LANGUE=0
2007
France
French
research
clinical trials, phase i as topic
clinical trials, phase ii as topic
clinical trials, phase iv as topic
drug evaluation
clinical trials, phase iii as topic
educational course

---
Nous contacter.
09/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.